A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study
Crossref DOI link: https://doi.org/10.1186/s13075-016-1091-1
Published Online: 2016-08-24
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stradner, Martin H.
Dejaco, Christian
Brickmann, Kerstin
Graninger, Winfried B.
Brezinschek, Hans Peter http://orcid.org/0000-0002-8939-0505
Funding for this research was provided by:
Roche (A)